Press Releases
Recro Pharma to Report Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019
Recro Pharma to Present at Upcoming Investor Conferences
Recro Pharma Reports First Quarter 2019 Financial Results
Recro Pharma to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 10, 2019
Recro Pharma Announces Six-Year Extension of License and Supply Agreement Between Teva and Recro Gainesville
Recro Pharma Announces Presentation of New Meta-Analysis for IV Meloxicam at the 44th Annual Regional Anesthesiology and Acute Pain Medicine Meeting
Recro Pharma Restructures Acute Care Segment While Continuing To Execute on Strong CDMO Segment Performance
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
Recro Pharma Receives Complete Response Letter from the FDA for Intravenous Meloxicam
